Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

פריטים דומים

• Long-term outcome after marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia using cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies
  מאת: Gupta, V, et al.
  יצא לאור: (2005)
• Favourable impact on acute and chronic graft-versus-host disease with cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia.
  מאת: Gupta, V, et al.
  יצא לאור: (2004)
• EVALUATION OF OUTCOME AND CHIMERIC STATUS FOLLOWING HLA IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA USING IN-VIVO CAMPATH-1G
  מאת: Hamblin, M, et al.
  יצא לאור: (1995)
• Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
  מאת: Hamblin, M, et al.
  יצא לאור: (1996)
• Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
  מאת: Vikas Gupta, et al.
  יצא לאור: (2010-12-01)